Alpha Profiles · Company Profile

Janux Therapeutics, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/janux-therapeutics-inc

Entity: Public listing published
Primary listing: NASDAQ: JANX
Verification: Partially verified
Last reviewed: 2026-09-13T04:46:05.661741+00:00

Overview

Alpha's canonical identity and public leadership record for Janux Therapeutics, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

10 public records

Byron Robinson

Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JANX executive roster sourceMay 3, 2026

Charles Winter

Chief Technical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187095Apr 28, 2026

David Campbell

Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JANX executive roster sourceMay 3, 2026

David Campbell, Ph.D.

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187095Apr 28, 2026

James Pennington

General Counsel and Corporate Secretary

State: confirmed
Effective: From Apr 28, 2026
Confidence: 94%
Evidence: JANX DEF 14A executive officersApr 28, 2026

Janeen Doyle

Chief Corporate and Business Development Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187095Apr 28, 2026

Thomas DiRaimondo

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JANX executive roster sourceMay 3, 2026

Thomas DiRaimondo, Ph.D.

Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187095Apr 28, 2026

Tighe Reardon

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: JANX executive roster sourceMay 3, 2026

William Go, M.D., Ph.D.

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-187095Apr 28, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 13, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.